A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study.

A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2016 Feb; 140(2):204-9.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Benzimidazoles
Bevacizumab
Carboplatin
Dose-Response Relationship, Drug
Doxorubicin
Drug Administration Schedule
Fallopian Tube Neoplasms
Female
Humans
Middle Aged
Neoplasm Recurrence, Local
Ovarian Neoplasms
Peritoneal Neoplasms
Polyethylene Glycols